Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.47 EUR | +1.38% | 0.00% | -16.24% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- Its low valuation, with P/E ratio at 7.65 and 4.83 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The stock, which is currently worth 2024 to 0.41 times its sales, is clearly overvalued in comparison with peers.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.24% | 27.33M | - | ||
-26.17% | 16.09B | A | ||
-41.25% | 2.9B | C+ | ||
+24.32% | 1.97B | - | ||
-9.90% | 1.53B | - | ||
+29.77% | 1.34B | B+ | ||
-17.38% | 953M | - | ||
-28.65% | 817M | - | C- | |
+2.36% | 807M | - | ||
-23.56% | 635M | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- IMD Stock
- Ratings I.M.D. International Medical Devices S.p.A.